BIOMAT Database Logo BIOMAT Database Logo

Detection of immunoglobulin M antibody in primary human immunodeficiency virus infection. 1988

H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Department of Infectious Diseases, Roslagstull Hospital, Karolinska Institute, Stockholm, Sweden.

Consecutive serum samples obtained from 20 homosexual men during symptomatic primary HIV infection were examined by a variety of IgG and IgM antibody assays. All sera obtained 2-5 weeks after onset of disease contained IgM anti-HIV as demonstrated by an IgM antibody capture assay. The IgM antibodies appeared during the 2 first weeks of illness, reached peak titres at 2-5 weeks and declined thereafter to undetectable levels at 2-3 months after the onset of disease. By contrast, IgG anti-HIV appeared later, during the second week after the onset of symptoms, and did not reach maximal levels until the IgM response had waned. The first IgM antibodies to appear were directed against gag proteins. IgM antibodies against env antigens were found less frequently and later in the course of the disease. These results suggest that IgM antibody determination may be helpful in the diagnosis of early HIV infection as a possible addition to the combined use of antigen detection and a second generation ELISA, which, in the present study, was found to be highly reliable for diagnostic purposes.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008297 Male Males
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Antibody response to human immunodeficiency virus after primary infection.
June 1987, The Journal of infectious diseases,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Duration of human immunodeficiency virus infection before detection of antibody.
September 1989, Lancet (London, England),
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Antibody in human immunodeficiency virus infection.
October 1993, Annals of the New York Academy of Sciences,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection.
September 1993, Journal of medical virology,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Fibrillary Glomerulonephritis with Atypical Immunoglobulin M Deposits and Hypocomplementemia Revealed Human Immunodeficiency Virus Infection.
January 2021, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection.
February 1994, The Pediatric infectious disease journal,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.
September 1992, Journal of clinical microbiology,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and reexposure to the virus.
January 1997, Viral immunology,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
[Symptomatic primary human immunodeficiency virus infection].
January 1997, La Revue de medecine interne,
H Gaines, and M von Sydow, and J V Parry, and M Forsgren, and P O Pehrson, and A Sönnerborg, and P P Mortimer, and O Strannegård
[Primary infection by human immunodeficiency virus].
January 1990, Annales de dermatologie et de venereologie,
Copied contents to your clipboard!